{
  "stages": {
    "EARLY": {
      "primary_treatments": ["Surgical Resection or Ablation"],
      "local": ["Resection", "Ablation"],
      "transplant": ["Eligible if Milan criteria"],
      "alternatives": ["Liver Transplantation", "Clinical Trial"],
      "follow_up": ["Imaging (CT/MRI) q3-6m"]
    },
    "INTERMEDIATE": {
      "primary_treatments": ["Transarterial Chemoembolization (TACE)"],
      "local": ["TACE"],
      "alternatives": ["TARE (Y90)", "Systemic Therapy", "Clinical Trial"],
      "follow_up": ["Imaging q3-6m"]
    },
    "ADVANCED": {
      "primary_treatments": ["Systemic Combination (Atezolizumab + Bevacizumab)"],
      "systemic": ["Atezolizumab + Bevacizumab", "Sorafenib", "Lenvatinib"],
      "viral": ["HBV/HCV treatment affects survival"],
      "alternatives": ["Durvalumab + Tremelimumab", "Cabozantinib", "Clinical Trial"],
      "follow_up": ["Imaging q6-12w"]
    }
  }
}
